Anticancer Medicine
Leading 100% Export Oriented Unit of clexcare 60mg enoxaparin sodium injection, nindacap 100mg nintedanib soft gelatin capsules, nindacap 150mg nintedanib soft gelatin capsules and alkros-one 250mg crizotinib tablet from Nagpur.
Clexcare 60mg Enoxaparin Sodium Injection
Product Price :Get Latest Price Product Details:
| Strength | 60 mg |
| Pack Size | 0.6 ml |
| Pack Type | Box |
| Brand Name | Clexcare |
| Manufacturer | Prevego |
Enoxaparin is used
to prevent blood clots in the leg in patients who are on bedrest or who are having hip replacement, knee replacement, or stomach surgery
Nindacap 100mg Nintedanib Soft Gelatin Capsules
Product Price :Get Latest Price Product Details:
| Strength | 100 mg |
| Brand | Nindacap |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer |
| Form | Capsule |
| Pack Type | Strip |
| Composition | Nintedanib 100mg |
| Manufacture | Prevego |
Nintedanib 100mg Soft Gelatin Capsule is used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. It works by targeting certain pathways involved in the growth and progression of these diseases and helps to stop or slow the spread of cancer cells.
Nindacap 150mg Nintedanib Soft Gelatin Capsules
Product Price :Get Latest Price Product Details:
| Strength | 150 mg |
| Brand | Nindacap |
| Capsules per Pack | 10 Capsules |
| Usage | Lung Cancer |
| Form | Capsule |
| Pack Type | Strip |
| Composition | Nintedanib 150mg |
| Manufacture | Prevego |
Nintedanib 150mg Soft Gelatin Capsule is used in the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. It works by targeting certain pathways involved in the growth and progression of these diseases and helps to stop or slow the spread of cancer cells.
Alkros-One 250mg Crizotinib Tablet
Product Price :Get Latest Price Product Details:
| Dose/Strength | 250 mg |
| Manufactured By | Intas |
| Content | Crizotinib 250mg |
| Packing Type | Box |
| Packing Size | 60 Capsules |
Crizotinib 250 mg is primarily used to treat adults with metastatic (advanced) non-small cell lung cancer (NSCLC) that is either anaplastic lymphoma kinase (ALK)-positive or ROS1-positive. It is also used to treat some pediatric and adult cancers with an ALK gene mutation. Crizotinib is a targeted therapy that works by blocking specific abnormal proteins that cause cancer cells to grow
